GeneDx Holdings (WGS) Cash from Operations (2020 - 2026)

GeneDx Holdings has disclosed Cash from Operations across 7 years of filings, most recently posting 32408000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 418.29% year-over-year to 32408000.0; the TTM figure through Mar 2026 stood at 9311000.0 (down 389.79% YoY), while the FY2025 annual figure was 33279000.0, up 216.78% from the prior year.
• Cash from Operations slipped to 32408000.0 in Q1 2026, from 3090000.0 in the prior quarter.
• Over the last five years, Cash from Operations for WGS reached as high as 15767000.0 in Q3 2025 and fell as low as 88362000.0 in Q3 2022.
• The 5-year median for Cash from Operations is 29858000.0 (2023), against an average of 30995705.88.
• Annual changes were most pronounced in 2025 — Cash from Operations jumped 458.75% — and 2026, when it slumped 418.29%.
• A 5-year view of Cash from Operations shows it stood at 64654000.0 in 2022, then jumped by 53.82% to 29858000.0 in 2023, then soared by 89.34% to 3183000.0 in 2024, then increased by 2.92% to 3090000.0 in 2025, then plunged by 948.8% to 32408000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 32408000.0, 3090000.0, and 15767000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.